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artery FMD in treated hypertensive heart transplant recipients. 
Methods FMD after release of a five minute transient upper arm occlusion (reactive 
hyperemia) was measured in the brachial artery of 15 stable male heart transplant recip- 
ients with chronic post-transplant hypertension (average age 54k9.7 years) taking one or 
more vasodilators before and 45 minutes after oral administratlon of sildenafil (50 mg). 
Arterial internal diameter (mm) was measured at end-d&t& from the anterior to the 
posterior intimal images using high resolution ultrasound and FMD calculated as the per- 
cent increase in diameter from baseline at 50 seconds after release of the occlusion. 
Also, for comparison baseline measurements of FMD were collected in a healthy age 
and gender matched control group of 13 normotensive subjects. 
Results: Brachial artery diameter was 4.5~ 0.4 mm at baseline and did not significantly 
change with sildenafil administration. Heart transplant recipients had impaired FMD 
(5.4*0.9% ) as compared with the healthy control group (7.1*2.5%, p<O.OOl). In the 
heart transplant recipients sildenafil administration increased FMD significantly from 
5.4*0.9% to 6.6+0.2% (p<O.Ol) and was a.sscciated with a reduction in systolic (from 
134klO to 126i6.9 mm Hg, p<O.Ol) and pulse (from 47+13 to 43+10 mm Hg, ~~0.01) 
blood pressure. 
Conclusions: The results from this study demonstrated that a smgle oral dose of 50 mg 
sildenafil acutely improves FMD !n the brachial artery of treated hypertensive male heart 
transplant recipients with endothelial dysfunction. These changes were associated with a 
reduction in peripheral arterial blood pressure. 
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832-2 Presence of Endothelial Dysfunction Is the Major 
Determinant of Maladaptive Vascular Remodeling in 
Brachial Arteries of Untreated Hypertensive Patients 
Tomoo Furumoto, Satoshi Fujii, Kelko Nishihara, Satoshi Yamada. Hisao Onozuka, 
Kaoru Komuro, Kazutomo Goto, Wu Di, Taisei Mikami, Hirotaka Nishijima, Akira 
Kitabatake, Hokkaido University, Sapporo, Japan 
Background: Flow-mediated dilation (FMD) of the brachial artery is a useful marker to 
detect endothelial dysfunction and early atherosclerosis. Although FMD is Impaired in 
patients with hypertension, the relationship between the hypertensive changes in vescu- 
lar morphology of brachial arteries and endothelial function remains undetermined. The 
a!m of this study was to assess the relation of FMD and wall thickness. Methods: Intima- 
media thickness (IMT) and FMD of brachial arteries were measured in untreated essen- 
tial hypertensives (56 * 6 yrs. n = 21) and age-matched normotensives (56 * 13 yrs, n = 
10) wng a newly developed electronic linear scanner with very high frequency (15 MHz) 
ultrasound. which was previously validated to have an adequate spatial resolution for 
precisely measuring IMT of brachial arteries. Brachial wall Stress was calculated from the 
internal diameter, IMT and systolic blood pressure. Results: IMT was significantly higher 
in hypertensives (0.36 r 0.06 mm) as compared with normotensives (0.27 * 0.05 mm, 
p<O.OOl), and FMD was significantly lower in hypertensives (3.6 * 1.5 %) as compared 
with normotensives (7.5 * 1.2 %, pcO.0001). However, among hypertensive patients 
%FMD correlated significantly with IMT (r = 0.54, pcO.O5), suggesting that brachial arter- 
ies with thicker IMT exhibited better endothelial function in the presence of high blood 
pressure, and %FMD inversely correlated with wall stress (r = -0.65, p<O.Ol). Conclu- 
sion: Thus, in brachial arteriesadaptive vascular remodeling suppresses the increase in 
wall stress Induced by hypertension. and prevents the development of endothellal dys- 
function. High-resolution ultrasound examination of the brachial artery structure and 
function may contribute to the assessment of adaptive favorable remodeling in hyperten- 
sive patients, and increase the diagnostic accuracy of non-invasive detection of low-risk 
hypertenwes. 
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832-3 Enhanced Vascular Activity of Endogenous Endothelin- 
1 in Obese Hypertensive Patients 
Carmine Cardtllo, Micaela lantomo, Umberto Campia, Julio A. Panza, Catholic 
University, Rome, Italy, Washington Hospital Center, Washington, DC 
Hypertenswe patients (HTs) have Increased endothelin (ET-l)-dependent vasoconstric- 
tor tone. The ET-l system, however, might not be uniformly activated in all forms of 
hypertension. as suggested by studies showing that ET-1 actiwty is enhanced predomi- 
nantly in low-renin, salt-sensitive hypertension models. This study sought to determine 
whether activation of the ET-l system in hypertension is associated with increased body 
mass Index (BMI). To this aim, forearm blood flow (FBF) responses (strain-gauge 
plethysmography) tc Intraarterial infusion of an ET, receptor blocker (BQ-123, 100 nmoll 
min for 60 min) were analyzed in HTs (1x27) and normotensive controls (NTs; n=28) 
according to BMI. BMI was evaluated both as a categorical (lean (LN), ~27 kg/m? over- 
weigth (OW), 27 to 29.9 kg/m’; obese (OB), $30 kg/my and as a continuous variable. As 
expected, FBF response to BQ-123 was significantly higher in HTs than in NTs 
(P<O.OOl). During 80-123, a significant increase in FBF from baseline was observed in 
OB HTs (n=ll; 26*6% (mean&EM); P<O.OOl) and OW HTs (n=7; 19*6%; P=O.O4). but 
not in LN HTs (n=9; 6*4%; P~0.63). In contrast, no significant change in F6F was 
observed during 80-123 in either OB NTs (n=9; 7*5%: P=O.53), or OW NTs (n=7; 
11 i6%; P=O.76), or LN NTs (n=9; 7+9%: P=O.93). In HTs, there was a significant correla- 
tion between BMI and the vasodilator response to ET, blockade (R=0.53; P=O.OOS), 
whereas no significant correlation was observed in NTs (R=O.li; P=O.56). FBF 
responses to exogenous ET-l (5 pmollmin for 60 mm) were also assessed in OB HTs 
(n=6) and OB NTs (n=7), to investigate possible differences in smooth muscle respon- 
Sweness to the peptide. ET-l infusion resulted in a. significant vasoconstrictor response 
I” both groups (decrease in FBF of 3522% in HTs and 33+2% in NTs; both PcO.001). 
without differences between them (P=O.56). In conclusion, in HTs increased BMI is asso- 
ciated with enhanced ETA-dependent vasoconstrictor activity, likely I” relation to 
increased vascular production of ET-l. These findings suggest that this abnormality may 
play a role in the pathophysiology of obesity-related hypertension and that ET-l receptor 
blockers may be effective to treat these patients. 
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832-4 Pleiotropic Hemodynamic Action of Statins in Rats 
Rendered Hypertensive by Inhibition of Nitric Oxide 
Synthesis 
Dinko Susie, Jasmina Varagic, lwar~ Ahn. Edward D. Frohlich, Ochsner Clinic 
Foundation, New Orleans, LA 
Background: Endothelial function and hemodynamics are Impaired in hypertension. We 
examined whether statins may improve hemodynamics in a model with endothelial dys- 
function exaggerated by nitric oxide synthesis inhibition. 
Methods: Control Wlstar-Kyoto rats received no treatment. The 2nd group was gwen 
nitric oxide synthesis inhibitor L-NAME (-15mgfkgIday) in drinking water. In addition to L- 
NAME the third group received rosuvastatin (R) (20mglkgiday) by gavage. After 6 
weeks, indexes of systemic and regional hemodynamics were measured in instrumented 
conscious rats. The following was measured: mean arterial pressure (MAP), cardiac 
index (Cl), total perrpheral resistance (TPR), renal blood flow (RBF) and resistance 
(RVR), coronary blood flow (CVR) and resistance (CVR), and, after dipyridamole infu- 
sion, minimal coronary vascular resistance (MCVR) and coronary flow reserve (CFR). 
Radlomicrospheres were used for flow measurements. 
Results: L-NAME adversely affected systemic and regional hemodynamics (Table), as 
evidenced by an increase in MAP and TPR, a decrease in Cl, and decreased organ 
blood flows with increased resistances. Statin therapy markedly improved these 
changes, with exception of MAP which remained elevated. Cholesterol levels were simi- 
lar. 
Controls L-NAME L-NAME + R 
MAP (mmHg) 99 f 6 156*5. 152 + 0” 
Cl (ml/mm/kg) 26%+36 119 * 15’ 172 * 10” 
TPRI (U/kg) 0.37 * 0.06 1.42 zt 0.26’ 0.91 * 0.06’# 
RBF (mllminig) 7.99 * 0.32 2.57 r 0.37’ 4.19*0.21.* 
RVR (U/g) 12.5 * 0.7 60.6 +z 1.5’ 36.6 * 3.5” 
CBF (mlimlnlg) 5.95*0.14 3.49 * 0.18’ 4.37 * 0.38’# 
CVR (U/g) 17.3 * 0.4 45.1 * 2.9‘ 34.9 * 3.28” 
MCVR (U/g) 7.4 * 0.3 34.9 f 2.4’ 18.3*1.6.~ 
CFR (ml/min/g) 6.38 + 0.12 1.09 * 0.24’ 3.69 f 0.46” 
Values are X * 1 SEM. .P<O.O5 “s control, ‘PcO.05 vs. L-NAME. 
Conclusion: Statin therapy exerted beneficial hemodynamic effects m rats with L-NAME 
hypertension. This is most likely medlated via an improvement in endothelial function. 
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832-5 Relationship of Soluble Angiopoietin Receptor Tie-2 to 
Tissue Factor, Endothelial Dysfunction, and Vascular 
Endothelial Growth Factor in Hypertension 
Natal1 A. Chunq, Gregory Y. Lip, City Hospital, Birmingham, Unlted Kingdom 
Background: We have developed an assay for a novel marker of angiogenesis, soluble 
angiopoietin receptor Tie-P, and aimed to study its relatmnship to indices of angiogenesis 
[vascular endothelial growth factor (VEGF) and its receptor sFlt-I], thrombogenesls [tis- 
sue factor (TF)] and endothellal dysfunction [van Willebrand factor (vWf) and flow medl- 
ated dilatation (FMD) of the brachial artery] in hypertension. Methods: FMD and plasma 
VEGF, sFlt-1, Tie-2, TF, and vWf (all ELISA) were measured in 40 untreated hyperten- 
we patients (28 male, mean age 56*11.6years. mean blood pressure (BP) 1611 
95mmHg) and compared to 20 healthy controls (13 male, mean age 61.l*lO.lyears). 
Results: Plasma levels of TF (~~0.023) and Tie-2 (p=O.O43) were significantly higher in 
patients compared to controls, but FMD was lower (p=O.O02). Levels of Tie-2 correlated 
with VEGF (Spearman, r&65, pcO.OOl), sFlt-I (r&69, pcO.001) and TF (r=0.34, 
p=O.O35). VEGF also correlated with sFlt-1 (0.60, p<O.OOl), TF (r=O 41, p=O.O09), vWf 
(r=O.32, ~~0.044) and FMD (r=0.34, p=O.O34). Conclusion: We have shown for the first 
time raised Tie-2 levels in hypertension, in association wtth abnormal thrombogenesls 
and endothelial function. These processes appear to be closely related and may have 
implications for the pathophysiology of cardiovascular complications associated with 
hypertension. 
